|
1ADZ
THE SOLUTION STRUCTURE OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR, NMR, 30 STRUCTURES
Deposited 1997-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
107–182(76 aa)
Fragment:FACTOR XA-BINDING DOMAIN (DOMAIN II)
|
Mutation:N-TERMINAL INS(DYKDDDDKL)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 4.5;310 K;Pressure 1
|
Resolution not provided
|
|
1IRH
The Solution Structure of The Third Kunitz Domain of Tissue Factor Pathway Inhibitor
Deposited 2001-10-02
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
210–270(61 aa)
Fragment:the third kunitz domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;298 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition
1mM the third kunitz domain of tissue factor pathway inhibitor U-15N; 20mM Na-phosphate buffer; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1mM the third kunitz domain of tissue factor pathway inhibitor U-15N, 13C; 20mM Na-phosphate buffer; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
1TFX
COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN
Deposited 1997-01-21
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
121–178(58 aa)
Fragment:FACTOR XA-BINDING DOMAIN, DOMAIN II
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.60 Å
|
|
1TFX
COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN
Deposited 1997-01-21
|
Different construct
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
121–178(58 aa)
Fragment:FACTOR XA-BINDING DOMAIN, DOMAIN II
|
Not recorded
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;pH 8.0
|
Resolution 2.60 Å
|
|
4DTG
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model
Deposited 2012-02-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain K
119–178(60 aa)
Fragment:Kunitz-type protease inhibitor domain 2 (UNP residues 119-178)
|
Not recorded
|
GOL GLYCEROL × 10
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
PGE TRIETHYLENE GLYCOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6;295 K;0.05 M CALCIUM CHLORIDE, 0.1 M MES, pH 6.0, 45% V/V PEG 200, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 1.80 Å
R-free 0.236
|
|
5NMV
Crystal structure of 2F22 Fab fragment against TFPI1
Deposited 2017-04-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain K
29–107(79 aa)
|
Not recorded
|
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;20 % PEG 3350
200 mM Potassium formate
|
Resolution 1.65 Å
R-free 0.202
|
|
6BX8
Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C)
Deposited 2017-12-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
50–107(58 aa)
|
Mutation:K64R, M66C, I83C
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2M Lithium Sulfate, 0.1M BIS-Tris-HCl pH 4.6, 25% v/v PEG 3350 (Anatrace Top96-27)
|
Resolution 1.98 Å
R-free 0.221
|
|
6BX8
Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C)
Deposited 2017-12-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
50–107(58 aa)
|
Mutation:K64R, M66C, I83C
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2M Lithium Sulfate, 0.1M BIS-Tris-HCl pH 4.6, 25% v/v PEG 3350 (Anatrace Top96-27)
|
Resolution 1.98 Å
R-free 0.221
|
|
6BX8
Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C)
Deposited 2017-12-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
50–107(58 aa)
|
Mutation:K64R, M66C, I83C
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2M Lithium Sulfate, 0.1M BIS-Tris-HCl pH 4.6, 25% v/v PEG 3350 (Anatrace Top96-27)
|
Resolution 1.98 Å
R-free 0.221
|
|
6BX8
Human Mesotrypsin (PRSS3) Complexed with Tissue Factor Pathway Inhibitor Variant (TFPI1-KD1-K15R-I17C-I34C)
Deposited 2017-12-18
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
50–107(58 aa)
|
Mutation:K64R, M66C, I83C
|
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2M Lithium Sulfate, 0.1M BIS-Tris-HCl pH 4.6, 25% v/v PEG 3350 (Anatrace Top96-27)
|
Resolution 1.98 Å
R-free 0.221
|
|
9P0X
Nanodisc-embedded human TF/FVIIa/XK1 in complex with 10H10 Fab (nanodisc-subtracted)
Deposited 2025-06-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain K
40–107(68 aa)
|
Not recorded
|
MG MAGNESIUM ION × 4
CA CALCIUM ION × 12
BGC beta-D-glucopyranose × 1
FUC alpha-L-fucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.70 Å
|